AADR vs BBC

Both AADR and BBC are ETFs. AADR has a higher 5-year return than BBC (2.23% vs -0.74%). AADR has a higher expense ratio than BBC (1.1% vs 0.79%). Below is the comparison between AADR and BBC.

AADR BBC
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: U.S. Biotech
Issuer AdvisorShares Virtus
Net Assets $61.1M $22.77M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.63% 0.00%
Underlying Index -- LifeSci Biotechnology Clinical Trials Index
YTD Return -21.89% -21.93%
1-Year Return -6.78% 5.95%
3-Year Return -2.67% 9.34%
5-Year Return 2.23% -0.74%
10-Year Return N/A N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR returns

YTD Return -21.89%
1-Month Return -19.74%
3-Month Return -22.48%
1-Year Return -6.78%
3-Year Return -2.67%
5-Year Return 2.23%
10-Year Return N/A
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (37.68% of Total Assets)

Name Symbol % Assets
Galapagos NV ADR GLPG 5.19%
NICE Ltd ADR NICE 4.62%
Cosan Ltd CZZ.SA 4.04%
argenx SE ADR ARGX 3.81%
Anglogold Ashanti Ltd ADR AU.JO 3.49%
Gold Fields Ltd ADR GFI.JO 3.38%
Airbus SE ADR EADSY.PA 3.33%
Allegion PLC ALLE 3.31%
LVMH Moet Hennessy Louis Vuitton SE ADR LVMUY.PA 3.27%
MercadoLibre Inc MELI.SA 3.24%

BBC description

The Fund seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering clinical trial stage of development.

BBC returns

YTD Return -21.93%
1-Month Return -15.49%
3-Month Return -24.98%
1-Year Return 5.95%
3-Year Return 9.34%
5-Year Return -0.74%
10-Year Return N/A
BBC expense ratio is 0.79%.

BBC holdings

Top 10 Holdings (15.32% of Total Assets)

Name Symbol % Assets
Intra-Cellular Therapies Inc ITCI 2.64%
Axsome Therapeutics Inc AXSM 2.17%
Cortexyme Inc CRTX 1.42%
Immunogen Inc IMGN 1.4%
Epizyme Inc EPZM 1.37%
Precision BioSciences Inc DTIL 1.33%
SpringWorks Therapeutics Inc Ordinary Shares SWTX 1.31%
Provention Bio Inc PRVB 1.25%
ChemoCentryx Inc CCXI 1.24%
Ascendis Pharma A/S ADR ASND 1.19%
Follow Us